Dabur Research Foundation
Dr. Anu Singh currently serves as Chief Operating Officer, Chief Scientific Officer, Vice President (R&D), and Director (R&D) at Dabur Research Foundation since July 2007, leading a team of 70 scientists in preclinical contract research services and responsible for achieving the organization's technical and business objectives. Dr. Anu Singh has successfully spearheaded innovations at Dabur, formed strategic partnerships, and expanded business into new regions such as the US, EU, and APAC. Prior experience includes establishing and leading the Molecular Oncology Unit at Dabur, and conducting post-doctoral research at the National Institute of Immunology and All India Institute of Medical Sciences. Dr. Anu Singh holds a Ph.D. in Endocrinology-Tumour Biology, a post-doctoral fellowship in signal transduction and molecular pharmacology, and an MTech in Biotechnology-Tumour Biology.
This person is not in any teams
This person is not in any offices
Dabur Research Foundation
Dabur Research Foundation (DRF) is an Indian Contract Research Organization Est.1979 offering preclinical services in Drug Discovery and Development, ranging from identification of potential lead molecules, drug development to IND enabling studies. We offer preclinical services to global Biotech, Pharma, Phytopharmaceuticals Cosmeceuticals and academia sectors. Our services broadly fall into the functional areas of In Vitro, Ex-Vivo & In Vivo Pharmacology, Exploratory & GLP Toxicology & DMPK. Our genesis is from the Dabur group of companies; we started operating as a preclinical service provider after a strategy spin-off from our parent company in the year 2008. It is this experience of 30 years of drug discovery & development that we bring to our clients as a preclinical service provider.